MAM
XBI icon

Marotta Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Marotta Asset Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
66,810
+702
+1% +$94.9K 1.74% 24
2026
Q1 		$8.5M Buy
66,108
+550
+0.8% +$68.7K 1.56% 24
2025
Q4 		$7.99M Sell
65,558
-8,302
-11% -$952K 1.48% 24
2025
Q3 		$7.49M Sell
73,860
-846
-1% -$76.2K 1.41% 25
2025
Q2 		$6.2M Buy
74,706
+12,776
+21% +$1.02M 1.24% 27
2025
Q1 		$6.12M Sell
61,930
-1,266
-2% -$113K 1.2% 25
2024
Q4 		$5.78M Buy
63,196
+1,266
+2% +$123K 1.21% 24
2024
Q3 		$6.12M Sell
61,930
-2,738
-4% -$269K 1.2% 25
2024
Q2 		$6.02M Sell
64,668
-456
-0.7% -$40.9K 1.24% 24
2024
Q1 		$6.18M Sell
65,124
-3,449
-5% -$320K 1.28% 25
2023
Q4 		$6.12M Buy
68,573
+611
+0.9% +$45.4K 1.31% 27
2023
Q3 		$4.96M Buy
67,962
+3,313
+5% +$265K 1.15% 28
2023
Q2 		$5.38M Buy
+64,649
New +$5.41M 1.2% 27
2022
Q4 		$5.02M Buy
60,540
+4,575
+8% +$370K 1.21% 30
2022
Q3 		$4.44M Sell
55,965
-1,157
-2% -$97.5K 1.16% 30
2022
Q2 		$4.37M Buy
57,122
+13,682
+31% +$1.03M 1.08% 30
2022
Q1 		$3.9M Buy
43,440
+4,748
+12% +$438K 0.91% 30
2021
Q4 		$4.33M Buy
38,692
+1,540
+4% +$186K 0.98% 28
2021
Q3 		$4.67M Buy
37,152
+1,171
+3% +$151K 1.13% 27
2021
Q2 		$4.98M Buy
35,981
+4,173
+13% +$549K 1.2% 27
2021
Q1 		$4.36M Buy
31,808
+4,513
+17% +$676K 1.11% 26
2020
Q4 		$3.84M Buy
27,295
+3,484
+15% +$446K 1.01% 28
2020
Q3 		$2.65M Buy
+23,811
New +$2.67M 0.81% 32

Other funds holding XBI

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

Marotta Asset Management's XBI Position: Q2 2026 in Review

Marotta Asset Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.1% in Q2 2026, buying an estimated $94.9K and bringing the position to 66,810 shares worth $10.5M. The position accounts for 1.74% of the portfolio, ranked #24.

Marotta Asset Management first reported a position in XBI in Q3 2020 and has held it in 23 quarters since. 415 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Marotta Asset Management held 66,810 shares of State Street SPDR S&P Biotech ETF worth $10.5M as of Q2 2026.
  • Marotta Asset Management bought 702 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $94.9K.
  • State Street SPDR S&P Biotech ETF made up 1.74% of Marotta Asset Management's portfolio in Q2 2026, its #24 holding.
  • Marotta Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 23 quarters since.
  • 415 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Marotta Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.